Home / MissionIR Articles / Cancer Genetics, Inc. (CGIX) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Cancer Genetics, Inc. (CGIX) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Cancer Genetics is a DNA-based cancer diagnostics company servicing some of the most prestigious medical institutions in the world. The company’s tests target hard-to-diagnose cancers such as hematological, urogenital and HPV-associated cancers. CGIX also provides a comprehensive range of non-proprietary oncology-focused tests and laboratory services. The company’s state-of-the-art reference lab is both CLIA certified and CAP accredited and has licensure from several states including New York State. For more information visit the company’s Web site at www.cancergenetics.com

Let us hear your thoughts below: